NumFin

Aytu BioPharma, Inc.

Sümbol: AYTU

NASDAQ

2.9043

USD

Turuhind täna

  • -0.9631

    P/E suhe

  • -0.0159

    PEG suhe

  • 16.17M

    MRK Cap

  • 0.00%

    DIV tootlus

Aytu BioPharma, Inc. (AYTU) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Aytu BioPharma, Inc. (AYTU) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 18.495 M, mis on 4.353 % gowth. Kogu perioodi keskmine brutokasum on 10.507 M, mis on 4.013 %. Keskmine brutokasumi suhtarv on 2.170 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.845 %, mis on võrdne -11.026 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Aytu BioPharma, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus -0.008. Käibevara valdkonnas on AYTU aruandlusvaluutas 72.832. Märkimisväärne osa neist varadest, täpsemalt 22.985, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 0.187%. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 14.713 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on -0.100%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 39.357 aruandlusvaluutas. Selle aspekti aastane muutus on -0.146%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 28.937, varude hind on 11.99 ja firmaväärtus 0, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 58.97.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

81.662319.449.6
48.1
11
7
0.8
9.1
7.4
2.6
0
0
0
0
0
0
0

balance-sheet.row.short-term-investments

0000
0
0
0
0
1
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

122.2728.921.728.2
5.2
1.7
0.6
0.5
0.2
0.2
0
0
0
0
0
0
0
0

balance-sheet.row.inventory

51.61210.816.3
10
1.4
1.3
1.3
0.5
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

4.130.90.61
5.7
1.2
0.5
0.4
0.3
0.5
0.7
0
0
0
0
0
0
0

balance-sheet.row.total-current-assets

293.2772.859.9105.2
75
15.4
9.5
3
10.1
8.1
3.3
0
0
0
0
0
0
0

balance-sheet.row.property-plant-equipment-net

15.73.96.38.7
0.9
0.2
0.2
0.6
0.2
0
0.1
0
0
0
0
0
0
0

balance-sheet.row.goodwill

00065.8
28.1
0
0
0.2
0.2
0.1
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

235.495970.685.5
48.9
19.1
11.4
11.1
13.6
9.7
8.2
0.8
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

235.495970.6151.3
76.9
19.1
11.4
11.3
13.8
9.8
8.2
0.8
0
0
0
0
0
0

balance-sheet.row.long-term-investments

-1.38-1.40-10.9
-1.8
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

1.381.4010.9
1.8
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

3.360.80.80.5
0
0
0
0
0.2
0.3
0.5
-0.8
0
0
0
0
0
0

balance-sheet.row.total-non-current-assets

254.5563.677.7160.4
77.9
19.3
11.6
12
14.2
10.1
8.7
0
0
0
0
0
0
0

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

547.82136.5137.6265.7
152.8
34.7
21.1
15
24.3
18.2
12
0
0
0
0
0
0.1
0.1

balance-sheet.row.account-payables

53.0913.51119.3
11.8
2.3
2.1
2.2
3.5
1.2
0.6
0
0
0
0
0
0
0

balance-sheet.row.short-term-debt

17.71.63.925.5
1.3
0
0
0
0
0
4.6
0.1
0.1
0.1
0.1
0.1
0
0

balance-sheet.row.tax-payables

0000
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

55.9214.714.32.8
0.7
0
0
0
0
-0.4
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

-1.38-1.40-11.2
-1.8
0
0
0
0
0.4
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

1.38---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

82.357.149.57.4
14.9
3.1
1.3
1.4
6.6
0.2
0.8
0
0
0
0
0
0
0

balance-sheet.row.total-non-current-liabilities

118.4528.127.118.7
29.5
22.3
4.2
7.4
4.2
1.1
0.6
0
0.1
0.1
0.1
0.1
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
-0.1
-0.1
-0.1
-0.1
0
0

balance-sheet.row.capital-lease-obligations

4.050.82.23.6
1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

402.5397.191.5128.1
57.8
27.6
7.6
11
14.3
2.6
6.6
0.1
0.1
0.1
0.1
0.1
0
0

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0000
0
0
0
0
0
0
0
0.4
0
0
0
0
0.2
0

balance-sheet.row.retained-earnings

-1230.52-304.1-288.5-178.3
-120
-106.4
-79.3
-69.1
-46.6
-18.4
-10.7
-0.6
0
0
0
-0.3
-0.2
-0.1

balance-sheet.row.accumulated-other-comprehensive-income-loss

0000
0
0
0
-0.2
-0.1
-5
0
10.5
-0.5
-0.5
-0.3
0
0
0

balance-sheet.row.other-total-stockholders-equity

1375.81343.5334.6315.9
215
113.5
92.7
73.3
56.8
39
16.1
-10.4
0.4
0.4
0.3
0.2
0
0.2

balance-sheet.row.total-stockholders-equity

145.2939.446.1137.6
95
7.1
13.4
4
10.1
15.6
5.4
-0.1
-0.1
0
-0.1
0
0
0

balance-sheet.row.total-liabilities-and-stockholders-equity

547.82136.5137.6265.7
152.8
34.7
21.1
15
24.3
18.2
12
0
0
0
0
0
0.1
0.1

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

145.2939.446.1137.6
95
7.1
13.4
4
10.1
15.6
5.4
-0.1
-0.1
0
-0.1
0
0
0

balance-sheet.row.total-liabilities-and-total-equity

547.82---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

-1.38-1.40-10.9
-1.8
0
0
0
1
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

73.6216.418.228.3
2
0
0
0
0
0
4.6
0.1
0.1
0.1
0.1
0.1
0
0

balance-sheet.row.net-debt

-8.04-6.6-1.2-21.3
-46.1
-11
-7
-0.8
-8.1
-7.4
2
0.1
0.1
0
0.1
0
0
0

Rahavoogude aruanne

Aytu BioPharma, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 0.822 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 15.57, mis tähistab -75.000 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 0, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus 0.000 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 2.38 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -117000.000. See on -0.964 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 8.81, -0.11, -2.35, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte 0 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui -4.36, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

-18-17.1-110.2-58.3
-13.6
-27.1
-10.2
-22.5
-28.2
-7.7
-5.6
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
0

cash-flows.row.depreciation-and-amortization

8.728.810.39.2
6.2
2.7
2.6
4.4
0.9
0.1
0.1
0
0
0
0
0
0
0

cash-flows.row.deferred-income-tax

7.313.3022.3
0.6
-0.1
-1.9
1.6
13.5
0
-0.8
0
0
0.1
0
0
0
0

cash-flows.row.stock-based-compensation

3.5565.23.6
1.1
1
0.3
2.5
0.9
1
0.5
0
0
0.1
0
0
0
0

cash-flows.row.change-in-working-capital

1.71-5.8-10.91.7
-12.6
-0.2
-0.7
-1
1.8
-0.1
0.3
0
0
0
0
0
0
0

cash-flows.row.account-receivables

-3.79-7.26.51.5
-3.6
-1.2
-0.1
-0.4
0
-0.2
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-2.57-3.61.32.8
-7
-0.1
0
0.2
-0.5
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

0.192.4-7.7-3.2
-1.4
0.1
-0.1
0.5
1.6
0.5
0.4
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

7.872.6-110.6
-0.7
0.9
-0.5
-1.4
0.7
-0.5
-0.2
-0.1
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

2.81-0.476.7-4.5
-10
9.8
-6
1.2
0.4
0.1
0
0
0
-0.1
0
0
0
0

cash-flows.row.net-cash-provided-by-operating-activities

6.11000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

000-2.3
0
-0.1
-0.1
-0.1
-2.3
0
0
0
0
0
0
0
0
0

cash-flows.row.acquisitions-net

00-3.2-2.8
0.2
-0.5
0
-4
-3.1
-1
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
-0.1
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

-0.4-0.1-0.12.4
-5.8
-0.5
-0.4
0.6
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

-0.4-0.1-3.2-2.8
-5.7
-1.1
-0.5
-3.5
-5.3
-1
0
0
0
0
0
0
0
0

cash-flows.row.debt-repayment

-2.39-2.3-172.5-54.9
-19.4
-5
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

3.9315.611.745.1
0
0
0.2
9.3
12.7
5
0
0
0
0
0
0
0.1
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
-0.9
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

-7.22-4.4162.340.2
90.5
24.1
22.4
0.8
4.8
7.4
5.2
0
0
0
0
0
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

-5.688.91.530.3
71.1
19.1
22.7
10.2
16.7
12.4
5.2
0
0
0.1
0
0
0.1
0

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0.033.6-30.51.6
37
4.2
6.2
-7.2
0.7
4.7
-0.3
0
0
0
0
0
0
0

cash-flows.row.cash-at-end-of-period

81.662319.449.9
48.3
11.3
7.1
0.9
8.1
7.4
2.6
0
0
0
0
0
0
0

cash-flows.row.cash-at-beginning-of-period

81.6319.449.948.3
11.3
7.1
0.9
8.1
7.4
2.6
2.9
0
0
0
0
0
0
0

cash-flows.row.operating-cash-flow

6.11-5.1-28.8-26
-28.4
-13.8
-15.9
-13.8
-10.7
-6.6
-5.5
0
0
-0.1
0
0
0
0

cash-flows.row.capital-expenditure

000-2.3
0
-0.1
-0.1
-0.1
-2.3
0
0
0
0
0
0
0
0
0

cash-flows.row.free-cash-flow

6.11-5.1-28.8-28.3
-28.4
-13.9
-16
-13.9
-12.9
-6.6
-5.5
0
0
-0.1
0
0
-0.1
0

Kasumiaruande rida

Aytu BioPharma, Inc. tulud muutusid võrreldes eelmise perioodiga 0.111%. AYTU brutokasum on teatatud 66.63. Ettevõtte tegevuskulud on 78.96, mille muutus võrreldes eelmise aastaga on -10.663%. Kulud amortisatsioonikulud on 8.81, mis on 0.177% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 78.96, mis näitab -10.663% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab -1.459% kasvu võrreldes eelmise aastaga. Tegevustulu on -17.07, mis näitab -1.459% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.845%. Eelmise aasta puhaskasum oli -17.05.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

98.5107.496.765.6
27.6
7.3
3.7
3.2
2.6
0.3
0.1
0
0
0
0
0
0
0

income-statement-row.row.cost-of-revenue

36.240.844.436.4
7.6
2.2
2.1
1.4
1
0.1
0
0
0
0
0
0
0
0

income-statement-row.row.gross-profit

62.2966.652.329.2
20.1
5.1
1.6
1.8
1.6
0.2
0.1
0.1
0
0
0
0
0
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

2.45---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

25.68---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

34.78---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-1.94-4.84.16
4.5
2.1
6.3
1.7
0.7
0
0
0
0
0
0
0
0
0

income-statement-row.row.operating-expenses

65.317988.467.4
41
22
19.5
20.7
15.8
7.8
6.4
0.1
0.1
0.1
0.1
0.1
0.1
0

income-statement-row.row.cost-and-expenses

101.52119.7132.8103.9
48.6
24.2
21.5
22.1
16.8
7.9
6.4
0.1
0.1
0.1
0.1
0.1
0.1
0

income-statement-row.row.interest-income

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

-3.860147.50
0
0
0.7
2.5
5.5
0.1
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

34.78---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-11.55-4.7-147.5-19.8
7.3
-10.3
8.4
-1.1
-8.5
-0.1
0
0
0
0
0
0
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-1.94-4.84.16
4.5
2.1
6.3
1.7
0.7
0
0
0
0
0
0
0
0
0

income-statement-row.row.total-operating-expenses

-11.55-4.7-147.5-19.8
7.3
-10.3
8.4
-1.1
-8.5
-0.1
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

-3.860147.50
0
0
0.7
2.5
5.5
0.1
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

5.714.84.123.7
-3.7
12.5
2.6
4.4
0.9
0.1
0.1
0
0
0
0
0
0
0

income-statement-row.row.ebitda-caps

-0.31---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-8.26-17.137.2-38.2
-20.9
-16.8
-19.7
-20.1
-21.7
-7.6
-6.3
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
0

income-statement-row.row.income-before-tax

-17.17-17.1-110.3-58
-13.6
-27.1
-10.2
-22.5
-28.2
-7.7
-6.4
-0.1
-0.1
-0.1
-0.1
-0.1
0
0

income-statement-row.row.income-tax-expense

1.25-0.1-0.10.3
-9.9
20
-2.1
1.1
8.5
0
-0.8
0.9
0
0
0
0
0
0

income-statement-row.row.net-income

-16.64-17.1-110.2-58.3
-3.7
-47.2
-10.2
-22.5
-28.2
-7.7
-5.6
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
0
Sarnased aktsiad
Sind võib huvitada ka:
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
TLLTF
TILT Holdings Inc..
0.0295 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
579.45 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
002693.SZ
Hainan Shuangcheng Pharmaceuticals Co., Ltd..
5.14 CNY
SHZ
ERIS.NS
Eris Lifesciences Limited.
892.95 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
990.25 INR
NSE
AVCNF
Avicanna Inc..
0.2653 USD
PNK

Korduma kippuv küsimus

Mis on Aytu BioPharma, Inc. (AYTU) koguvara?

Aytu BioPharma, Inc. (AYTU) koguvara on 136463000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on 45033000.000.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.632.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 1.108.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -0.169.

Mis on ettevõtte kogutulu?

Kogutulu on -0.084.

Mis on Aytu BioPharma, Inc. (AYTU) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -17051000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 16361000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 78961000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 19529000.000.